Title:
NEW BIOMARKER FOR AML
Document Type and Number:
WIPO Patent Application WO/2015/169906
Kind Code:
A8
Abstract:
The present invention relates to an in vitro method for predicting the survival time of a subject suffering from acute myeloid leukemia (AML) comprising determining, in a biological sample from the subject, the epigenetic profile of the H3K27.
Inventors:
DUPREZ ESTELLE (FR)
CALMELS BORIS (FR)
VEY NORBERT (FR)
TIBERI GUILLAUME (FR)
CALMELS BORIS (FR)
VEY NORBERT (FR)
TIBERI GUILLAUME (FR)
Application Number:
PCT/EP2015/060081
Publication Date:
November 17, 2016
Filing Date:
May 07, 2015
Export Citation:
Assignee:
INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE) (FR)
INST JEAN PAOLI & IRENE CALMETTES (FR)
CENTRE NAT DE LA RECH SCIENT (CNRS) (FR)
UNIVERSITÉ D'AIX MARSEILLE (FR)
INST JEAN PAOLI & IRENE CALMETTES (FR)
CENTRE NAT DE LA RECH SCIENT (CNRS) (FR)
UNIVERSITÉ D'AIX MARSEILLE (FR)
International Classes:
C12Q1/68
Attorney, Agent or Firm:
HIRSCH, Denise (7 rue Watt, Paris, FR)
Download PDF:
Previous Patent: METHOD FOR PROVIDING AN OBJECT PREDICTION REPRESENTATION
Next Patent: METHOD FOR DETERMINING AN EVASIVE PATH FOR A HOST VEHICLE
Next Patent: METHOD FOR DETERMINING AN EVASIVE PATH FOR A HOST VEHICLE